Test Directory

Test Code
1099
Test Name
Pfeiffer Syndrome
CPT Codes
81404, 81479
Included Tests
FGFR1 Exon 10 and FGFR2 Exons 8 & 10 only
Expected Turnaround Time
Typically 1 to 2 weeks from receipt of a sample in the laboratory. All cases involving ongoing pregnancies will be expedited.
Clinical Utility
Genetic analysis to provide a molecular diagnosis of this disorder. Recommended for individuals with a personal and/or family history of this disorder to ensure appropriate treatment and establish recurrence risk for family members.
Specimen and Container Info

Non-Prenatal Specimens

Preferred/Alternate

Specimen Type

Containers

Volume

Preferred Specimen Type

Whole Blood

Lavender Top (EDTA)

3 mL

Alternate Specimen Type

Genomic DNA

1.5 mL Tube

3 µg (at a concentration of at least 30 ng/µl), preferably in TE solution.

Alternate Specimen Type

Fibroblasts

T-25 Flasks

2 confluent T-25 flasks, filled to capacity

Alternate Specimen Type

Saliva (Whole blood is recommended for CNV)

DNA Self-Collection Kit or Oragene Saliva Collection Kit for Young Children

Follow kit instructions (www.dnagenotek.com)

Prenatal Specimens

Either specimen type below is acceptable.

Specimen Type

Containers

Volume

Cultured cells

T-25 Flasks

2 confluent T-25 flasks derived from amnio or CVS samples.

Genomic DNA

1.5 mL Tube

3 µg (at a concentration of at least 30 ng/µl), preferably in TE solution.

NOTE: For specimens from outside of North America, the preferred specimen type is Genomic DNA. HNL Genomics does not recommend shipping whole blood or cultured cells from any location other than the United States, Canada, or Mexico.

Transport Instructions
  • Transport at room temperature within 24 hours.
  • If the specimen cannot be transported to the lab within 24 hours, refrigerate for up to 72 hours.
  • Do not freeze or expose to extreme temperatures, refrigerate for up to 72 hours if cannot be transported to lab within 24 hours. 
Stability Requirements

Room Temperature

24 hours

Refrigerated

72 hours

Causes for Rejection
  • Improperly labeled specimen (minimum of two patient identifiers)
  • Inappropriate specimen type
  • Incomplete or incorrect test request form
  • Insufficient volume
  • Specimen has leaked in transit
  • Specimen without a test order
Methodology
Sanger Sequencing
Performing Location
Genomics - Snowdrift
Description

Pfeiffer syndrome - The craniosynostosis syndromes are a group of disorders sharing the premature fusion of one or more sutures of the skull. Often additional anomalies are associated. There are eight craniosynostosis disorders caused by mutations in three fibroblast growth factor receptor genes: FGFR1, FGFR2 and FGFR3. All are autosomal dominant. Penetrance varies with the specific craniosynostosis type. Many FGFR mutations are associated with advanced paternal age.

Pfeiffer syndrome (MIM 101600) patients have craniosynostosis with broad thumbs and/or great toes that are medially deviated.  Brachydactyly and variable degrees of syndactyly may occur.  Pfeiffer syndrome has been divided into three subtypes.  Type 1 is clinically the least severe and has the best prognosis. Patients have bicoronal craniosynostosis, moderate to severe midface hypoplasia and they usually have a normal life span and normal intelligence. About 5% of Pfeiffer syndrome type 1 patients have a specific FGFR1 mutation and about 95% have FGFR2 mutations. Pfeiffer syndrome type 2 patients have cloverleaf skulls, severe ocular proptosis, neurodevelopmental problems, elbow and knee ankylosis and foreshortened life spans. Type 3 is similar to type 2 but the skull is turribrachycephalic and patients also die young.  Type 2 and Type 3 are caused by FGFR2 mutations. Penetrance is complete and expressivity is variable in Pfeiffer syndrome.  Sporadic as well as familial cases occur. The prevalence of Pfeiffer syndrome is estimated as 1:100,000.

Testing Schedule
Monday-Friday
Genes
FGFR1, FGFR2
MIM
101600
Disease Group
Craniosynostosis and Craniofacial Disorders